SAN DIEGO, Oct. 15 – “We have seen the future and it is not us,” Huntington Willard, president of the American Society of Human Genetics, said during his address to the group during its annual meeting here on Saturday. 

While calling genetics the “hottest field in the business,” he complained of slowing membership at the ASHG even as attendance at meetings for genomics-oriented organizations skyrocket. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.